Ashish Agarwal

94 posts

Ashish Agarwal

Ashish Agarwal

@agarwal1975

Founder, Solvuu

New York, NY Katılım Mart 2010
281 Takip Edilen223 Takipçiler
Ashish Agarwal retweetledi
Solvuu
Solvuu@solvuu·
CAR-T/BCMA therapy drastically enhanced the survival of relapsed/refractory multiple myeloma patients. However, high relapse rates and short remission times call for a more profound exploration. scRNAseq can offer valuable mechanistic insights. Learn how👇 hubs.ly/Q02hyXbz0
English
1
3
8
468
Ashish Agarwal
Ashish Agarwal@agarwal1975·
@echo_nyc @solvuu We hope so too! We are keen to leverage our software and bioinformatics expertise to more companies working in this space.
English
0
0
2
128
Derek Brand
Derek Brand@echo_nyc·
Really like what Ashish and his team @solvuu are building - this type of analysis should be highly relevant for patient selection for CAR-T therapies and I hope we can use tools like this to identify responders/non-responders to improve both outcomes and access
Solvuu@solvuu

CAR-T therapy is an emerging treatment option of high potential for B cell malignancies. Single-cell RNA-seq bioinformatics can help in target prediction for CAR-T and accelerate its promising success. To learn more👇 hubs.ly/Q02gM-B10

English
1
0
3
512
Ashish Agarwal retweetledi
Solvuu
Solvuu@solvuu·
Analytical validation of NGS panels for both somatic and germline variants in molecular diagnostics is still challenging. This is difficult because of the limitations in obtaining physical samples with the repertoire of variants capable of being detected by the assay. 1/3🧵
English
2
3
4
161
Ashish Agarwal retweetledi
Solvuu
Solvuu@solvuu·
NGS-based Laboratory Developed Tests (LDTs) play a crucial role in clinical decision-making. Different types of 𝘪𝘯 𝘴𝘪𝘭𝘪𝘤𝘰 data have been suggested for validating NGS assays and bioinformatics pipelines. To learn more👇 linkedin.com/feed/update/ur…
English
0
3
3
145
Ashish Agarwal retweetledi
Solvuu
Solvuu@solvuu·
ELVAR is a novel approach to single-cell RNA-seq analysis, which employs cell-attribute-aware clustering and enables accurate detection of cell-type composition changes. @AMaity5485 developed ELVAR prior to joining us. To learn more, click the link👇 linkedin.com/posts/solvuu_c…
English
0
4
3
195
Ashish Agarwal retweetledi
Solvuu
Solvuu@solvuu·
We are thrilled to welcome Alok Kumar Maity to @solvuu's growing team! Alok is a statistical and computational systems biologist and he joins us following postdoctoral positions at the prestigious @UCAS1978 in Shanghai and @UCLA. Learn more here👇 linkedin.com/posts/solvuu_c…
English
0
3
5
269
Ashish Agarwal
Ashish Agarwal@agarwal1975·
Great talk by my friend Suman. I could sense the enthusiasm in the room. Wanted to say hi to him after but couldn’t get past all the investors who surrounded him first.
Biolabs@NYULangone@BioLabsNY

Our resident @SUMANLA60766567 CEO of DECK THerapeutics @BioLabsNY, a privately-held company developing an injectable Omega 3 to treat stroke patients, interviews with @proactive_NA #BiotechShowcase #JPM2020 #healthcareconference proactiveinvestors.com/companies/news…

English
0
0
1
0
Tomasz Cichociński
Tomasz Cichociński@_cichocinski·
Not looking for switch but out of curiosity - who is looking for @reasonml developers? Both remote and not.
English
6
6
11
0
Ashish Agarwal retweetledi
Solvuu
Solvuu@solvuu·
Solvuu is very excited to be at #ASHG2019. A warm welcome and Presidential address by Leslie Biesecker.
Solvuu tweet media
English
0
4
4
0